ArticleDEN open2025
Feasibility of endoscopic ultrasound-guided hepaticogastrostomy using a novel long balloon catheter.
Article in DEN open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- EUS-Guided Choledochoduodenostomy Versus Hepaticogastrostomy in Case of Concomitant Gastric Outlet Obstruction Treated by EUS-Guided Gastroenterostomy: A Systematic Review and Meta-Analysis.United European gastroenterology journal · 2026Pooled it
- One-step plastic stent placement using endoscopic ultrasound-guided hepaticogastrostomy without tract dilation in obstructive jaundice.Endoscopy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Recently, a novel long balloon catheter for tract dilation in endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) was developed. The balloon measures 6 cm in length, which enables one-step tract dilation of the gastric wall, liver parenchyma, and bile duct wall, contributing to shorter procedure times and reduced bile leakage. This study investigated the feasibility of EUS-HGS with this new balloon catheter. Methods: This retrospective study included consecutive cases in which EUS-HGS was performed using a novel long balloon catheter (3 mm in diameter) for malignant distal biliary obstructions between February 2024 and October 2024. The patients' clinical background and procedural details were retrospectively examined using medical records. The primary outcome was technical success, defined as successful stent placement without additional dilation using devices other than the new balloon catheter. The secondary outcomes were clinical success and adverse events. Results: This study included 10 patients. The median age was 82.5 years, and there were seven males and three females. The median procedure time was 20 min. Technical success was achieved in 90% and clinical success was achieved in 100%. Regarding adverse events, one patient developed moderate cholecystitis, and percutaneous transhepatic gallbladder drainage was performed. No bile leakage, peritonitis, bleeding, or perforation was observed. Conclusion: The new long balloon catheter is an excellent device that can reliably dilate the whole tract with a single inflation. EUS-HGS using a novel long balloon catheter is a feasible treatment option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.